An evaluation of the need for shared blood donor deferral registries

International Journal for Quality in Health Care

Volumn 9, Issue 1, 1997, Pages 35-41

  Domen, Ronald E ^a,d   Grewal, Indira D ^b   Hirschler, Nora V ^c   Hoeltge, Gerald A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b AMERICAN RED CROSS BLOOD SERVICES   (United States)

^c Section of Blood Banking and Transfusion   (United States)

^d Blood Centers of the Pacific   (United States)

Author keywords

Adverse transfusion effects; Blood banking; Blood banks; Blood donor motivation; Blood donors; Donor deferral registry; Transfusion medicine

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; HUMAN; PATIENT SCHEDULING; PATIENT SELECTION; PRIORITY JOURNAL; REGISTER;

BLOOD BANKS; BLOOD DONORS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFECTION CONTROL; INTERINSTITUTIONAL RELATIONS; OHIO; REGIONAL MEDICAL PROGRAMS; REGISTRIES;

EID: 0030980238     PISSN: 13534505     EISSN: None     Source Type: Journal    
DOI: 10.1093/intqhc/9.1.35     Document Type: Article

References (25)

1. Sherwood W C, Donor deferral registries. Transfus MedRev 1993; 7: 121-128.
2. Code of Federal Regulations 21:606.160(e), 1994.
3. Klein H G, ed.: Standards for blood banks and transfusion services. M2. 116. 16th ed. Bethesda: American Association of Blood Banks, 1994.
4. Ellis F R, Friedman L I and Wirak B F, A computerized national blood donor deferral register. JAMA 1975; 232: 722-724.
5. Silvergleid A J, Donor screening. Clinics Lab Med 1992; 12: 669-683.
6. Grossman B J and Springer K M, Blood donor deferral registries: highlights of a conference. Transfusion 1992; 32: 868-872.
7. Memorandum to all registered blood and plasma establishments. Guidance regarding post donation information reports. Bethesda, Maryland: Center for Biologies Evaluation and Research, Food and Drug Administration, December 10, 1993.
8. Wallas C H and Hoffman J A, Memorandum to A ABB institutional members: management of hearsay information about blood donors. Association Bulletin #93-4. Bethesda, Maryland: American Association of Blood Banks, December 2, 1993.
9. Mollison P L, Engelfriet C P and Contreras M, Blood Transfusion in Clinical Medicine. Ninth edition. Boston: Blackwell Scientific Publications: 1993.
10. Infectious Disease Testing for Blood Transfusions. NIH Consensus Statement 1995; Jan. 9-11, 13 (1), 1-27.
11. Myhre B A, Jiminez L and Shitabata P, The correlations of surrogate markers with anti-hepatitis C virus and other disease markers. Ann Clin Lab Sei 1994; 24: 76-83.
12. Polesky H F, Safety in tranfusion practices: preventing infectious complications. Clin Lab Med 1992; 12: 701-710.
13. Sayers M H, Changing relationships between blood donors, community physicians and blood centers. Vox Sang 1994; 67(suppl.): 261-264.
14. Doll L S, Petersen L R and White C R, Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. Transfusion 1991; 31: 704-709.
15. Kleinman S H, Interview studies of HIV seropositive donors. Vox Sang 1994; 67(suppl.): 265-266.
16. Piliavin J A and Callero P L, Giving blood: the development of an altruistic identity. Baltimore: The Johns Hopkins University Press: 1991.
17. Domen R E, Blood donation and individuals arrested for prostitution (Abstract). Transfusion 1992; 32(suppl.): 29S.
18. Morbidity and Mortality Weekly Report 43(2). Atlanta, Georgia: Centers for Disease Control and Prevention, October 28, 1994.
19. Petersen L R, Lackritz E and Lewis W F, The effectiveness of the confidential unit exclusion option. Transfusion 1994; 34: 865-869.
20. Korelitz J J, Williams A E and Busch M P, Demographic characteristics and prevalence of serologie markers among donors who use the confidential unit exclusion process: the Retrovius Epidemiology Donor Study. Transfusion 1994; 34: 870-876.
21. Domen R E, The confidential unit exclusion and allogeneic blood donation: results from supplementary questions to the donor center and viral markers surveys of the College of American Pathologists. Arch Palhol Lab Med 1995; 119: 1007-1011.
22. Bradley D W, Virology, molecular biology, and serology of hepatitis C virus. Transfus Med Rev 1992; 6: 93-102.
23. Alter M J, Review of serologie testing for hepatitis C virus infection and risk of posttransfusion hepatitis C. Arch PatholLab Med 1994; 118: 342-345.
24. Cordell R R, Yalon V A and Cigahn-Haskell C, Experience with 11,916 designated donations. Transfusion 1986; 26: 484-486.
25. Yalon V and Perkins H A, The arguments for directed donations. Transfus Sei 1989; 10: 131-137.